Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|February 26, 2010
Novel CCR5 antagonists for the treatment of HIV infection: a review of compounds patented in 2006 - 2008Hanbiao Yang, David M RotsteinChemistry (Weinheim an Der Bergstrasse, Germany)|July 23, 2011
Total syntheses of bryostatins: synthesis of two ring-expanded bryostatin analogues and the development of a new-generation strategy to access the C7-C27 fragmentBarry M Trost, Hanbiao Yang, Guangbin DongOrganic Letters|October 8, 2005
A Ru-catalyzed tandem alkyne-enone coupling/Michael addition: synthesis of 4-methylene-2,6-cis-tetrahydropyransBarry M Trost, Hanbiao Yang, Georg WuitschikJournal of the American Chemical Society|January 8, 2004
A formal synthesis of (-)-mycalamide ABarry M Trost, Hanbiao Yang, Gary D ProbstChemistry (Weinheim an Der Bergstrasse, Germany)|July 21, 2011
Atom-economic and stereoselective syntheses of the ring a and B subunits of the bryostatinsBarry M Trost, Hanbiao Yang, Cheyenne S Brindle, et al.Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Novel prodrug approach to amprenavir-based HIV-1 protease inhibitors via O-->N acyloxy migration of P1 moietyWieslaw M Kazmierski, Patricia Bevans, Eric Furfine, et al.Bioorganic & Medicinal Chemistry|June 6, 2003
Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitorsWieslaw Kazmierski, Neil Bifulco, Hanbiao Yang, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|July 28, 2011
Total synthesis of bryostatins: the development of methodology for the atom-economic and stereoselective synthesis of the ring C subunitBarry M Trost, Alison J Frontier, Oliver R Thiel, et al.Bioorganic & Medicinal Chemistry Letters|November 19, 2008
Discovery of a potent, selective and orally bioavailable 3,9-diazaspiro[5.5]undeca-2-one CCR5 antagonistHanbiao Yang, Xiao-Fa Lin, Fernando Padilla, et al.Journal of Medicinal Chemistry|September 25, 2008
Discovery of bioavailable 4,4-disubstituted piperidines as potent ligands of the chemokine receptor 5 and inhibitors of the human immunodeficiency virus-1Wieslaw M Kazmierski, Christopher Aquino, Brian A Chauder, et al.Pageof 2